School of Medicine

Neuroendocrine Tumors Ongoing Research:

• Development of novel radiolabeled peptides for intraoperative tumor localization, scintigraphy, and in situ radiotherapy.
• Development of in vitro models of human angiogenesis.
• Alterations in gene expression during the transformation of human blood vessels from the quiescent to proliferative phenotype.
• A clinical trial of a new somatostalin analog, SOM-230, for the treatment of Carcinoid Syndrome.
• Development of lipophilic somatostatin analogs for
  in situ radiotherapy.
• Development of hydrophilic somatostatin analogs for
  in situ radiotherapy.
• Development of in vitro / in vitro modeling techniques for the administration of radiolabeled peptides.
• A clinical trial of thalidomide as an anti-tumor agent in patients with carcinoid tumors.

About the Neuroendocrine Tumor Program:

Clinical Research

Recent Awards: